Clinical Trials Update: Nov. 17, 2006

HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Chronic Pain

This study will evaluate the safety and effectiveness of Kadian NT when taken for chronic pain over a period of up to one year. Volunteers 18-70 with a history of chronic moderate-to-severe pain for at least three months may qualify.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat45.html.

Wal-Mart adds 11 more states to $4 generics plan

CHICAGO (Reuters) - Wal-Mart Stores Inc. said on Thursday it would begin selling certain generic prescription drugs for $4 in 11 new states, including Massachusetts, bringing the total to 38 states.

The world's biggest retailer, which launched the $4 generic drug program in Florida in September, said the program would be available in Washington, Idaho, Kentucky, Maine, Massachusetts, Nebraska, Oklahoma, Rhode Island, South Carolina, Utah and West Virginia as of Thursday.

The cut-price drugs are now available in 3,009 pharmacies. Wal-Mart has 3,960 U.S. stores.

Wal-Mart said the list of generics, which includes some 143 compounds, represents more than one-fourth of the prescriptions dispensed in its pharmacies nationwide.